Cargando…
Lupus Nephritis Risk Factors and Biomarkers: An Update
Lupus nephritis (LN) represents the most severe organ manifestation of systemic lupus erythematosus (SLE) in terms of morbidity and mortality. To reduce these risks, tremendous efforts have been made in the last decade to characterize the different steps of the disease and to develop biomarkers in o...
Autores principales: | Renaudineau, Yves, Brooks, Wesley, Belliere, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572905/ https://www.ncbi.nlm.nih.gov/pubmed/37833974 http://dx.doi.org/10.3390/ijms241914526 |
Ejemplares similares
-
Mesangial Cell-Specific Antibodies Are Central to the Pathogenesis of Lupus Nephritis
por: Seret, Guillaume, et al.
Publicado: (2012) -
Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011) -
Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013) -
Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020) -
Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis
por: Nie, Huiyu, et al.
Publicado: (2023)